A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

The Centers for Medicare & Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Trump administration said Friday that Medicare and Medicaid won’t expand coverage of popular anti-obesity drugs, ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for Wegovy and Zepbound ...

This decision is a blow for Eli Lilly and Novo Nordisk, who had both previously endorsed the proposed expansion.

high-demand obesity treatments under the federal government’s Medicare program. The Centers for Medicare and Medicaid ...

Democrat senators are begging Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. to keep a proposed Biden-era rule pertaining to obesity drugs. In November, the […] ...